Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:e9054-e9055
doi: 10.1161/hc2401.094237
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SoRelle, R.

(Circulation. 2001;103:e9054.)
© 2001 American Heart Association, Inc.

Cardiovascular News

Ruth SoRelle, MPH, Circulation Newswriter

Using Skeletal Muscle Cells to Repair Ailing Hearts

On May 11, 2001, physicians at the University of California at Los Angeles Medical Center transplanted skeletal muscle cells into damaged areas of a Nevada man’s heart in an attempt to repair the damage from repeated myocardial infarctions. The experimental technique took place during coronary artery bypass surgery, but the cells were placed in an area where bypass could not reperfuse the tissue.

The myocytes, which were taken from the patient’s arm, were grown in a laboratory for 10 to 14 days before the surgery. The lab-grown cells were then given back to the patient. These cells are capable of dividing and differentiating into a form that is more similar to cardiac muscle cells than those of the skeleton.

"This procedure is for patients with extensive ischemia and heart failure," said Greg Fonarow, MD, coinvestigator of the project and an assistant professor at the University of California at Los Angeles. Eventually, 4 to 5 centers will be involved in the first phase of testing. Physicians will assess the success of the technique with serial positron emission tomography scans of the affected area. Serial echocardiograms will be used to determine if the cell transplants have improved heart function.

"We are doing extensive safety monitoring," said Dr Fonarow. Concerns about the safety of the technique are theoretical, and there have been no problems in extensive animal trials. The cells are seeded into the heart by injection; they probably divide through 3 to 4 cycles and then remain in place, leaving the area . . . [Full Text of this Article]